Masimo is a global medical technology company that develops noninvasive patient monitoring technologies. Its best-known product is Masimo SET Measure-through Motion and Low Perfusion pulse oximetry, introduced in 1995 and built on adaptive signal processing to deliver accurate readings when patients move or perfusion is low. The technology is now an industry standard and serves as the primary pulse oximetry technology in 9 of the top 10 U.S. hospitals, with Masimo technologies monitoring more than 200 million patients each year.
The company's technical work spans adaptive signal processing, pulse oximetry, noninvasive blood constituent monitoring, brain function monitoring, capnography, patient monitoring and connectivity, remote patient monitoring and wearable health technology. Products include rainbow Pulse CO-Oximetry for noninvasive blood constituent monitoring beyond traditional pulse oximetry, SedLine for brain function monitoring, capnography solutions, and Root, a patient monitoring and connectivity platform. Beyond the hospital, SafetyNet provides remote monitoring for care at home, while the Masimo W1 health watch extends the company's noninvasive monitoring into consumer healthcare.
Masimo was founded in 1989 by engineer Joe Kiani as a garage startup, with a mission to solve problems considered unsolvable and to take noninvasive monitoring to new sites and applications. Its stated focus is on improving patient care and reducing costs. The company operates globally, with technologies deployed from hospital wards to home care settings across medical technology, healthcare, patient monitoring and consumer wearables.
